bNovate Technologies Stock

bNovate Technologies develops fully automated analysis instruments.

Sign up today and learn more about bNovate Technologies Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About bNovate Technologies Stock

bNovate Technologies SA was founded in 2011 with the goal to be the best in the field of automated cells analysis. The company is based at the Innovation Park of the Swiss Federal Institute of Technology of Lausanne (EPFL). They started their activities with a few people. Today, bNovate Technologies SA has grown into a strong team of scientific experts and managers who can address the challenge of developing the most demanding, fully automated analysis instruments. They develop instruments for clients, but they also created their own cell detection instruments for drinking water that they distribute through partnering companies.

Funding History

May 2021$5.0M
January 2023$175K
June 2023$12.0M


CEO R&D and Operations, Founder and Board Member

Simon Künzi

CEO Sales & Marketing

René Lenggenhager

Board Member

Dimitri Boulanger

Board Member

Helge Daebel


Ronald Strässler

Chief Marketing Officer & Account Manager

Céline Jaeger


Luigino Grasso


Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: